{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 449870016
| IUPAC_name = 1-{(''E'')-2-(Methylthio)-1-[2-(pentyloxy)phenyl]vinyl}-1''H''-imidazole
| image = Neticonazole.svg

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|neticonazole}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number =  
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 5282433
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = KVL61ZF9UO
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 4445587

<!--Chemical data-->
| chemical_formula =  
| C=17 | H=22 | N=2 | O=1 | S=1 
| molecular_weight = 302.43 g/mol
| smiles            = CCCCCOc1ccccc1/C(=C\SC)/n2ccnc2
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C17H22N2OS/c1-3-4-7-12-20-17-9-6-5-8-15(17)16(13-21-2)19-11-10-18-14-19/h5-6,8-11,13-14H,3-4,7,12H2,1-2H3/b16-13+
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = VWOIKFDZQQLJBJ-DTQAZKPQSA-N
}}

'''Neticonazole''' ([[International Nonproprietary Name|INN]]) is an [[imidazole]] [[Antifungal medication|antifungal]] for the treatment of fungal skin infections.<ref>{{cite journal |vauthors=Nimura K, Niwano Y, Ishiduka S, Fukumoto R |title=Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan |journal=Int. J. Antimicrob. Agents |volume=18 |issue=2 |pages=173–8 |date=August 2001 |pmid=11516941 |doi= 10.1016/S0924-8579(01)00365-X|url=http://linkinghub.elsevier.com/retrieve/pii/S0924-8579(01)00365-X}}</ref><ref>{{cite journal |vauthors=Tsuboi R, Matsumoto T, Ogawa H |title=Hyperkeratotic chronic tinea pedis treated with neticonazole cream. Neticonazole Study Group |journal=Int. J. Dermatol. |volume=35 |issue=5 |pages=371–3 |date=May 1996 |pmid=8734665 |doi= 10.1111/j.1365-4362.1996.tb03644.x|url=}}</ref>

Neticonazole is only approved for use in [[Japan]]. It is sold as a topical ointment under the tradename '''Atolant'''.

==References==
{{Reflist}}

{{Antifungals}}

[[Category:Phenol ethers]]
[[Category:Thioethers]]
[[Category:Alkene derivatives]]
[[Category:Imidazole antifungals]]
[[Category:Lanosterol 14α-demethylase inhibitors]]


{{antiinfective-drug-stub}}